BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23624566)

  • 1. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS.
    Killoran A; Biglan KM; Jankovic J; Eberly S; Kayson E; Oakes D; Young AB; Shoulson I
    Neurology; 2013 May; 80(22):2022-7. PubMed ID: 23624566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease: how intermediate are intermediate repeat lengths?
    Squitieri F; Jankovic J
    Mov Disord; 2012 Dec; 27(14):1714-7. PubMed ID: 23008174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).
    Quaid KA; Eberly SW; Kayson-Rubin E; Oakes D; Shoulson I;
    Clin Genet; 2017 Jun; 91(6):824-831. PubMed ID: 27740685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
    Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
    J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlates of mitochondrial function in Huntington's disease muscle.
    Turner C; Cooper JM; Schapira AH
    Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington disease.
    Marder K; Gu Y; Eberly S; Tanner CM; Scarmeas N; Oakes D; Shoulson I;
    JAMA Neurol; 2013 Nov; 70(11):1382-8. PubMed ID: 24000094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the correlates of intermediate CAG repeats in Huntington disease.
    Ha AD; Jankovic J
    Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
    Savitt D; Jankovic J
    J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the clinical expression of intermediate CAG repeat length mutations of the Huntington's disease gene.
    Panegyres PK; Shu CC; Chen HY; Paulsen JS
    J Neurol; 2015 Feb; 262(2):277-84. PubMed ID: 25380582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.
    ; Dorsey E
    PLoS One; 2012; 7(2):e29522. PubMed ID: 22359536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young Adults.
    Schultz JL; Saft C; Nopoulos PC
    Neurology; 2021 May; 96(19):e2407-e2413. PubMed ID: 33692166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset Huntington disease with intermediate CAG repeats: true or false?
    Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation for Huntington disease following maternal transmission of an intermediate allele.
    Semaka A; Kay C; Belfroid RD; Bijlsma EK; Losekoot M; van Langen IM; van Maarle MC; Oosterloo M; Hayden MR; van Belzen MJ
    Eur J Med Genet; 2015 Jan; 58(1):28-30. PubMed ID: 25464109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.